Related Experiment Video

Updated: Mar 13, 2026

Author Spotlight: Innovations in iTUG Test for Enhanced Risk Assessment and Cognitive Insights
05:26

Author Spotlight: Innovations in iTUG Test for Enhanced Risk Assessment and Cognitive Insights

Published on: October 25, 2024

1.9K

Understanding the situation and challenges of falls prevention work in clinical settings for geriatric healthcare in

Qi Zhou1, Jiling Liao2, Hengshuo Liu1

  • 1Department of Basic Innovation Research, Beijing Hospital, National Center for Gerontology; National Clinical Research Center for Gerontology; The Key Laboratory of Geriatrics of NHC; Beijing Key Laboratory of Aging Mechanism and Intervention Research On Aging-Related Diseases, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 10073, China.

BMC Geriatrics
|March 12, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Barriers and facilitatorsClinical practiceFallsFalls preventionGeriatric medicineHospitalsInpatientOlder adultsOutpatientThe world falls prevention guideline

More Related Videos

Design and Analysis for Fall Detection System Simplification08:05

Design and Analysis for Fall Detection System Simplification

Published on: April 6, 2020

11.2K
Community-based Adapted Tango Dancing for Individuals with Parkinson's Disease and Older Adults09:19

Community-based Adapted Tango Dancing for Individuals with Parkinson's Disease and Older Adults

Published on: December 9, 2014

26.4K

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
307